Swiss Re AG

Swiss Re reported H1 2026 net income of USD 2.8 billion, which management said was more than 60% of its full-year net income target of USD 4.5 billion. P&C Reinsurance delivered an insurance service result of USD 1.8 billion and a combined ratio of 76.7%; the current-service experience benefit was around USD 350 million, and large nat cat losses came in USD 676 million below expectations, including USD 391 million in Q2. Life & Health Re reported net income of just over USD 1 billion, with an insurance service result of USD 1.2 billion and a CSM release of USD 758 million, corresponding to an annualized release rate of around 9%. Corporate Solutions posted a combined ratio of 86.1% and an insurance service result of USD 578 million. The investment portfolio produced an ROI of 4.0% and recurring income of USD 2 billion. Management reiterated P&C Re’s full-year combined ratio target of below 85%, reaffirmed the USD 1.7 billion 2026 net income target for Life & Health Re, and said the group SST ratio was estimated at 264%.

Andreas Berger framed the quarter as evidence that Swiss Re’s diversified model and cycle-management approach are working, pointing to strong underwriting, disciplined pricing, and balance-sheet strength. He emphasized that the company is maintaining underwriting discipline even in competitive markets, with particular attention to preserving portfolio quality, prudent loss picks, and expanding cycle-decorrelated business lines. He also highlighted the announced cost-reduction target increase to USD 500 million by 2028 as part of simplifying the group and improving efficiency.

Anders Malmstrom emphasized the specific drivers behind the half-year results: favorable nat cat experience, reserve releases in short-tail lines, and additional prudence added to long-tail IBNR reserves. He noted P&C Re’s USD 1.8 billion insurance service result, the USD 1 billion of short-tail reserve releases, the USD 500 million addition to long-tail IBNR in Q2, and the 76.7% combined ratio. He also cited Life & Health Re’s USD 1.2 billion insurance service result, USD 758 million of CSM release, ROI of 4.0%, recurring income of USD 2 billion, and the 264% SST ratio, while saying the group had executed about 60% of the USD 1.5 billion buyback by the end of July.

Analysts focused on how much of the strong reserve releases are structural versus temporary, whether added long-tail reserves signaled worsening trends, and how much of the lower new business CSM was due to prudence versus lower business volumes. Management said the reserve releases reflected the new reserving philosophy and unusually benign nat cat experience, not deterioration, and that the long-tail additions were simply prudent strengthening rather than a sign of worsening claims trends. On Life & Health, management said new business CSM is still lumpy and transaction-driven, but the long-run objective remains CSM sustainability above 100%; they expect the second half to return to a more normal run rate, though not necessarily back to 100% for the year. On casualty, management said rate increases are being offset by prudently higher loss assumptions and that its market positioning remains disciplined.